Literature DB >> 34816399

Reverse Genetics and Its Usage in the Development of Vaccine Against Poultry Diseases.

Barnali Nath1, Sudhir Morla1, Sachin Kumar2.   

Abstract

Vaccines are the most effective and economic way of combating poultry viruses. However, the use of traditional live-attenuated poultry vaccines has problems such as antigenic differences with the currently circulating strains of viruses and the risk of reversion to virulence. In veterinary medicine, reverse genetics is applied to solve these problems by developing genotype-matched vaccines, better attenuated and effective live vaccines, broad-spectrum vaccine vectors, bivalent vaccines, and genetically tagged recombinant vaccines that facilitate the serological differentiation of vaccinated animals from infected animals. In this chapter, we discuss reverse genetics as a tool for the development of recombinant vaccines against economically devastating poultry viruses.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Avian coronavirus; Avian influenza; Newcastle disease; Poultry; Reverse genetics; Vaccines

Mesh:

Substances:

Year:  2022        PMID: 34816399     DOI: 10.1007/978-1-0716-1888-2_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  72 in total

Review 1.  Redesign and genetic dissection of the rhabdoviruses.

Authors:  A Roberts; J K Rose
Journal:  Adv Virus Res       Date:  1999       Impact factor: 9.937

Review 2.  A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?

Authors:  Gabriele Neumann; Michael A Whitt; Yoshihiro Kawaoka
Journal:  J Gen Virol       Date:  2002-11       Impact factor: 3.891

Review 3.  Nonsegmented negative-strand RNA viruses: genetics and manipulation of viral genomes.

Authors:  K K Conzelmann
Journal:  Annu Rev Genet       Date:  1998       Impact factor: 16.830

4.  Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs.

Authors:  A Bridgen; R M Elliott
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

5.  A DNA transfection system for generation of influenza A virus from eight plasmids.

Authors:  E Hoffmann; G Neumann; Y Kawaoka; G Hobom; R G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

6.  Cloned poliovirus complementary DNA is infectious in mammalian cells.

Authors:  V R Racaniello; D Baltimore
Journal:  Science       Date:  1981-11-20       Impact factor: 47.728

7.  Rescue of influenza A virus from recombinant DNA.

Authors:  E Fodor; L Devenish; O G Engelhardt; P Palese; G G Brownlee; A García-Sastre
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

8.  The evolution of H5N1 influenza viruses in ducks in southern China.

Authors:  H Chen; G Deng; Z Li; G Tian; Y Li; P Jiao; L Zhang; Z Liu; R G Webster; K Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-02       Impact factor: 11.205

9.  Mapping of the influenza virus genome: identification of the hemagglutinin and the neuraminidase genes.

Authors:  P Palese; J L Schulman
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

10.  The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities.

Authors:  Kelvin K W To; Jasper F W Chan; Honglin Chen; Lanjuan Li; Kwok-Yung Yuen
Journal:  Lancet Infect Dis       Date:  2013-09       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.